| SpectraBase Spectrum ID |
8JoBzgcssfA |
| Name |
4-(2-[2-Methylindol-3-yl]ethyl)morpholine |
| Classification |
Tryptamine designer drug analog |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
244.157563271 u |
| Formula |
C15H20N2O |
| InChI |
InChI=1S/C15H20N2O/c1-12-13(6-7-17-8-10-18-11-9-17)14-4-2-3-5-15(14)16-12/h2-5,16H,6-11H2,1H3 |
| InChIKey |
VJKRVNBXXWRHRA-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
244.338 g/mol |
| Nominal Mass |
244 u |
| Quality |
992 |
| Retention Index |
2233 |
| SMILES |
C=12C(NC(=C2CCN2CCOCC2)C)=CC=CC1 |
| SPLASH |
splash10-0udi-1900000000-be3880b5b8bcf62318ce |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Morpholine,4-(2-[2-methylindol-3-yl]ethyl)
2-methyl-3-(2-(morpholin-4-yl)ethyl)-1H-indole |
| Technique |
GC/MS |
| Wiley ID |
DD2024_016284 |
![4-(2-[2-Methylindol-3-yl]ethyl)morpholine](/api/spectrum/8JoBzgcssfA/structure.png?h=300&w=458 "4-(2-[2-Methylindol-3-yl]ethyl)morpholine")
